Nakao, Keiko
Kobuchi, Shinji http://orcid.org/0000-0002-4694-4651
Marutani, Shuhei
Iwazaki, Ayano
Tamiya, Akihiro http://orcid.org/0000-0003-3599-2583
Isa, Shunichi
Okishio, Kyoichi
Kanazu, Masaki
Tamiya, Motohiro
Hirashima, Tomonori
Imai, Kimie
Sakaeda, Toshiyuki
Atagi, Shinji
Article History
Received: 5 August 2019
Accepted: 18 November 2019
First Online: 3 December 2019
Competing interests
: S.A. has received grants and personal fees from Boehringer Ingelheim, MSD, Chugai, Ono, AstraZeneca, Taiho, Lilly, Pfizer, and Bristol-Myers Squibb. S.A. also has received personal fees from Hisamitsu. A.T. has received the grant from AstraZeneca, Ono and Bristol-Myers Squibb. A.T. also has received the personal fees from AstraZeneca, Ono, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, Taiho, Kissei, and MSD. M.T. has received grants and personal fees from Boehringer Ingelheim Ono, and Bristol-Myers Squibb. M.T. also has received personal fees from Taiho Pharmaceutical, Eli Lilly, Asahi Kasei, MSD, AstraZeneca, and Chugai. T.H. has received grants and personal fees from Ono, Lilly Japan, AstraZeneca, Chugai, Taiho, MSD, and Bristol-Myers Squibb. T.H. also has received grants from Merck Serono, personal fees from Boehringer Ingelheim, and Pfizer. K.O. reports personal fees from Ono, MSD. K.N., S.K., S.M., A.I., S.I., M.K., K.I., and T.S. have nothing to disclose.